Human Immunodeficiency Virus-Associated Lung Malignancies

Clinics in Chest Medicine

Volumn 34, Issue 2, 2013, Pages 255-272

  Lambert, Allison A ^a,b   Merlo, Christian A ^a,b   Kirk, Gregory D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antiretroviral therapy; Cigarette smoking; HIV AIDS; Kaposi sarcoma; Lung cancer; Non Hodgkin lymphoma

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVANCED CANCER; CANCER MORTALITY; CANCER RISK; CHRONIC INFLAMMATION; CLINICAL FEATURE; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; LUNG CANCER; LUNG INFECTION; MORTALITY; NONHODGKIN LYMPHOMA; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SMOKING;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; LUNG NEOPLASMS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; SARCOMA, KAPOSI; SMOKING;

EID: 84878133743     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2013.01.008     Document Type: Review

References (117)

1. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338(13):853-860.
2. Sterne J.A., Hernan M.A., Ledergerber B., et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005, 366(9483):378-384.
3. Detels R., Munoz A., McFarlane G., et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998, 280(17):1497-1503.
4. Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000, 355(9210):1158-1159.
5. High K.P., Brennan-Ing M., Clifford D.B., et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012, 60(Suppl 1):S1-S18.
6. Hasse B., Ledergerber B., Furrer H., et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011, 53(11):1130-1139.
7. van Sighem A.I., Gras L.A., Reiss P., et al. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS 2010, 24(10):1527-1535.
8. Crum N.F., Riffenburgh R.H., Wegner S., et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006, 41(2):194-200.
9. Kirk G.D., Merlo C.A. HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc 2011, 8(3):326-332.
10. Engels E.A., Pfeiffer R.M., Goedert J.J., et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006, 20(12):1645-1654.
11. Frisch M., Biggar R.J., Engels E.A., et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001, 285(13):1736-1745.
12. Engels E.A., Biggar R.J., Hall H.I., et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008, 123(1):187-194.
13. Cancer facts & figures 2011 2011, American Cancer Society, Atlanta, GA.
14. Irwin L.E., Begandy M.K., Moore T.M. Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome. Ann Intern Med 1984, 100(1):158.
15. Sigel K., Wisnivesky J., Gordon K., et al. HIV as an independent risk factor for incident lung cancer. AIDS 2012, 26(8):1017-1025.
16. Kirk G.D., Merlo C., O' Driscoll P., et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007, 45(1):103-110.
17. Chaturvedi A.K., Pfeiffer R.M., Chang L., et al. Elevated risk of lung cancer among people with AIDS. AIDS 2007, 21(2):207-213.
18. Shiels M.S., Cole S.R., Kirk G.D., et al. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009, 52(5):611-622.
19. Gambus G., Bourboulia D., Esteve A., et al. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 2001, 15(9):1167-1174.
20. Renwick N., Halaby T., Weverling G.J., et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998, 12(18):2481-2488.
21. Kramer A., Biggar R.J., Hampl H., et al. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Am J Epidemiol 1992, 136(1):71-80.
22. Gallafent J.H., Buskin S.E., De Turk P.B., et al. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 2005, 23(6):1253-1260.
23. Huang L., Schnapp L.M., Gruden J.F., et al. Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy. Am J Respir Crit Care Med 1996, 153(4 Pt 1):1385-1390.
24. Aboulafia D.M. The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 2000, 117(4):1128-1145.
25. Angeletti P.C., Zhang L., Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol 2008, 56:509-557.
26. Palmieri C., Dhillon T., Thirlwell C., et al. Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV Med 2006, 7(5):291-293.
27. Murray J.F., Mason R.J. Murray and Nadel's textbook of respiratory medicine 2010, ScienceDirect (Online service), Saunders/Elsevier, Philadelphia, Available at:, Accessed December 20, 2012. http://www.mdconsult.com/public/book/view%3Ftitle=Mason:+Murray+%26+Nadel%27s+Textbook+of+Respiratory+Medicine, 5th edition.
28. Ognibene F.P., Steis R.G., Macher A.M., et al. Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 102(4):471-475.
29. Lodi S., Guiguet M., Costagliola D., et al. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst 2010, 102(11):784-792.
30. Gruden J.F., Huang L., Webb W.R., et al. AIDS-related Kaposi sarcoma of the lung: radiographic findings and staging system with bronchoscopic correlation. Radiology 1995, 195(2):545-552.
31. Gasparetto T.D., Marchiori E., Lourenco S., et al. Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology. Orphanet J Rare Dis 2009, 4:18.
32. Lee V.W., Fuller J.D., O'Brien M.J., et al. Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 1991, 180(2):409-412.
33. Biggar R.J., Engels E.A., Ly S., et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005, 39(3):293-299.
34. Stebbing J., Sanitt A., Nelson M., et al. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Lancet 2006, 367(9521):1495-1502.
35. Feller L., Anagnostopoulos C., Wood N.H., et al. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol 2008, 79(2):362-368.
36. Bower M., Nelson M., Young A.M., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005, 23(22):5224-5228.
37. Leidner R.S., Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 2005, 19(10):635-644.
38. Achenbach C.J., Harrington R.D., Dhanireddy S., et al. Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis 2012, 54(3):424-433.
39. Stover K.R., Molitorisz S., Swiatlo E., et al. A fatal case of Kaposi sarcoma due to immune reconstitution inflammatory syndrome. Am J Med Sci 2012, 343(5):421-425.
40. Cadranel J.L., Kammoun S., Chevret S., et al. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994, 49(10):958-960.
41. Kirova Y.M., Belembaogo E., Frikha H., et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases. Radiother Oncol 1998, 46(1):19-22.
42. Simard E.P., Pfeiffer R.M., Engels E.A. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2011, 117(5):1089-1096.
43. Cadranel J., Naccache J., Wislez M., et al. Pulmonary malignancies in the immunocompromised patient. Respiration 1999, 66(4):289-309.
44. Restrepo C.S., Chen M.M., Martinez-Jimenez S., et al. Chest neoplasms with infectious etiologies. World J Radiol 2011, 3(12):279-288.
45. Knowles D.M. Biologic aspects of AIDS-associated non-Hodgkin's lymphoma. Curr Opin Oncol 1993, 5(5):845-851.
46. Ray P., Antoine M., Mary-Krause M., et al. AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 1998, 158(4):1221-1229.
47. Cesarman E., Chang Y., Moore P.S., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332(18):1186-1191.
48. Eisner M.D., Kaplan L.D., Herndier B., et al. The pulmonary manifestations of AIDS-related non-Hodgkin's lymphoma. Chest 1996, 110(3):729-736.
49. Miller R.F., Jones E.L., Duddy M.J., et al. Progressive intrathoracic lymphadenopathy: EBV associated non-Hodgkin's lymphoma. Sex Transm Infect 2002, 78(1):13-17.
50. Allen C.M., Al-Jahdali H.H., Irion K.L., et al. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med 2010, 5(4):201-216.
51. Gerard L., Galicier L., Maillard A., et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 2002, 30(5):478-484.
52. Kirk O., Pedersen C., Cozzi-Lepri A., et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001, 98(12):3406-3412.
53. Re A., Michieli M., Casari S., et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood 2009, 114(7):1306-1313.
54. Huhn G.D., Badri S., Vibhakar S., et al. Early development of non-Hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients-implications for immune reconstitution. AIDS Res Ther 2010, 7:44.
55. Shiels M.S., Pfeiffer R.M., Gail M.H., et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011, 103(9):753-762.
56. Cadranel J., Garfield D., Lavole A., et al. Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 2006, 61(11):1000-1008.
57. Engels E.A., Brock M.V., Chen J., et al. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006, 24(9):1383-1388.
58. Shiels M.S., Cole S.R., Mehta S.H., et al. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr 2010, 55(4):510-515.
59. Spano J.P., Massiani M.A., Bentata M., et al. Lung cancer in patients with HIV Infection and review of the literature. Med Oncol 2004, 21(2):109-115.
60. Silverberg M.J., Chao C., Leyden W.A., et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011, 20(12):2551-2559.
61. Bower M., Powles T., Nelson M., et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 2003, 17(3):371-375.
62. Grulich A.E., van Leeuwen M.T., Falster M.O., et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370(9581):59-67.
63. Guiguet M., Boue F., Cadranel J., et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009, 10(12):1152-1159.
64. Meng Q., Walker D.M., Olivero O.A., et al. Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci U S A 2000, 97(23):12667-12671.
65. Wistuba I.I., Behrens C., Milchgrub S., et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA 1998, 279(19):1554-1559.
66. Chaturvedi A.K., Gaydos C.A., Agreda P., et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 2010, 19(6):1498-1505.
67. Alavanja M.C., Brownson R.C., Boice J.D., et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992, 136(6):623-632.
68. Brownson R.C., Alavanja M.C. Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control 2000, 11(9):853-858.
69. Engels E.A. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 2008, 8(4):605-615.
70. Shebl F.M., Engels E.A., Goedert J.J., et al. Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr 2010, 55(3):375-379.
71. Syrjanen K.J. HPV infections and lung cancer. J Clin Pathol 2002, 55(12):885-891.
72. Demopoulos B.P., Vamvakas E., Ehrlich J.E., et al. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med 2003, 127(5):589-592.
73. Brock M.V., Hooker C.M., Engels E.A., et al. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 2006, 43(1):47-55.
74. Shiels M.S., Pfeiffer R.M., Engels E.A. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010, 153(7):452-460.
75. Hakimian R., Fang H., Thomas L., et al. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2007, 2(4):268-272.
76. Suneja G., Shiels M.S., Melville S.K., et al. Disparities in the treatment and outcomes of lung cancer among HIV-infected people in Texas. AIDS 2013, 27(3):459-468.
77. Rengan R., Mitra N., Liao K., et al. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol 2012, 13(12):1203-1209.
78. Riedel D.J., Mwangi E.I., Fantry L.E., et al. High cancer-related mortality in an Urban, predominantly African-American, HIV-infected population. AIDS 2012, [Epub ahead of print].
79. Aboulafia D.M. Decision making in non-AIDS-defining malignancies. Lancet Oncol 2012, 13(12):1172-1173.
80. Rudek M.A., Flexner C., Ambinder R.F. Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol 2011, 12(9):905-912.
81. Persad G.C., Little R.F., Grady C. Including persons with HIV infection in cancer clinical trials. J Clin Oncol 2008, 26(7):1027-1032.
82. Lee A.Y., Levine M.N. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003, 107(23 Suppl 1):I17-I21.
83. Auerbach E., Aboulafia D.M. Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy. Semin Thromb Hemost 2012, 38(8):830-838.
84. Klein S.K., Slim E.J., de Kruif M.D., et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005, 63(4):129-136.
85. Rasmussen L.D., Dybdal M., Gerstoft J., et al. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med 2011, 12(4):202-210.
86. Fultz S.L., McGinnis K.A., Skanderson M., et al. Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med 2004, 116(6):420-423.
87. Ahonkhai A.A., Gebo K.A., Streiff M.B., et al. Venous thromboembolism in patients with HIV/AIDS: a case-control study. J Acquir Immune Defic Syndr 2008, 48(3):310-314.
88. Jacobson M.C., Dezube B.J., Aboulafia D.M. Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis 2004, 39(8):1214-1222.
89. George S.L., Swindells S., Knudson R., et al. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases. Am J Med 1999, 107(6):624-630.
90. Aberg J.A., Kaplan J.E., Libman H., et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009, 49(5):651-681.
91. Gritz E.R., Vidrine D.J., Lazev A.B., et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004, 6(1):71-77.
92. Marshall M.M., Kirk G.D., Caporaso N.E., et al. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav 2011, 36(1-2):61-67.
93. Crothers K., Griffith T.A., McGinnis K.A., et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005, 20(12):1142-1145.
94. Burkhalter J.E., Springer C.M., Chhabra R., et al. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005, 7(4):511-522.
95. Burns D.N., Kramer A., Yellin F., et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection?. J Acquir Immune Defic Syndr 1991, 4(1):76-83.
96. Conley L.J., Bush T.J., Buchbinder S.P., et al. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 1996, 10(10):1121-1126.
97. Aberle D.R., Adams A.M., Berg C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365(5):395-409.
98. Gold J.A., Rom W.N., Harkin T.J. Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest 2002, 121(5):1472-1477.
99. Lichtenberger J.P., Sharma A., Zachary K.C., et al. What a differential a virus makes: a practical approach to thoracic imaging findings in the context of HIV infection-part 2, extrapulmonary findings, chronic lung disease, and immune reconstitution syndrome. Am J Roentgenol 2012, 198(6):1305-1312.
100. Parker M.S., Leveno D.M., Campbell T.J., et al. AIDS-related bronchogenic carcinoma: fact or fiction?. Chest 1998, 113(1):154-161.
101. Grulich A.E., Wan X., Law M.G., et al. Risk of cancer in people with AIDS. AIDS 1999, 13(7):839-843.
102. Cooksley C.D., Hwang L.Y., Waller D.K., et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 1999, 10(12):795-802.
103. Grulich A.E., Li Y., McDonald A., et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002, 16(8):1155-1161.
104. Allardice G.M., Hole D.J., Brewster D.H., et al. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer 2003, 89(3):505-507.
105. Dal Maso L., Franceschi S., Polesel J., et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003, 89(1):94-100.
106. Newnham A., Harris J., Evans H.S., et al. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 2005, 92(1):194-200.
107. Mbulaiteye S.M., Katabira E.T., Wabinga H., et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 2006, 118(4):985-990.
108. Galceran J., Marcos-Gragera R., Soler M., et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007, 43(6):1085-1091.
109. Dal Maso L., Polesel J., Serraino D., et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009, 100(5):840-847.
110. Polesel J., Franceschi S., Suligoi B., et al. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010, 127(6):1437-1445.
111. Serraino D., Boschini A., Carrieri P., et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000, 14(5):553-559.
112. Phelps R.M., Smith D.K., Heilig C.M., et al. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001, 94(5):753-757.
113. Herida M., Mary-Krause M., Kaphan R., et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003, 21(18):3447-3453.
114. Clifford G.M., Polesel J., Rickenbach M., et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005, 97(6):425-432.
115. Serraino D., Piselli P., Busnach G., et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007, 43(14):2117-2123.
116. Patel P., Hanson D.L., Sullivan P.S., et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008, 148(10):728-736.
117. Levine A.M., Seaberg E.C., Hessol N.A., et al. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol 2010, 28(9):1514-1519.